FDA approves first marijuana-based prescription drug
WASHINGTON — The U.S. Food and Drug Administration has approved a marijuana-derived drug for the treatment of two rare and serious forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, that begin in childhood but can persist in adulthood. The drug is made from purified cannabidiol (CBD), a compound found in the cannabis plant. The drug
